Serum brain-derived neurotrophic factor and the risk for dementia

JAMA

Volumn 311, Issue 16, 2014, Pages 1684-1685

  Aisen, Paul S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; AGE; AGED; ALLELE; ALZHEIMER DISEASE; APOE4 GENE; COHORT ANALYSIS; COMMUNITY ASSESSMENT; DEMENTIA; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT;

ALZHEIMER DISEASE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEMENTIA; FEMALE; HUMANS; MALE;

EID: 84898825880     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.3120     Document Type: Note

References (10)

1. Weinstein G, Wolf PA, Beiser AS, Au R, Seshadri S. Risk estimations, risk factors, and genetic variants associated with Alzheimer's disease in selected publications from the Framingham Heart Study. J Alzheimers Dis. 2013;33(suppl 1):S439-S445.
2. Cummings JL. Biomarkers in Alzheimer's disease drug development. Alzheimers Dement. 2011;7(3):e13-e44.
3. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):280-292.
4. Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med. 2011;3(111):11cm33.
5. Lu B, Figurov A. Role of neurotrophins in synapse development and plasticity. Rev Neurosci. 1997;8(1):1-12. (Pubitemid 27354654)
6. Nagahara AH, Merrill DA, Coppola G, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med. 2009;15(3):331-337.
7. Weinstein G, Beiser AS, Choi SH, et al. Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol. 2014;71(1):55-61.
8. Aisen PS, Schneider LS, Sano M, et al Alzheimer Disease Cooperative Study. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA. 2008;300(15):1774-1783.
9. Lyketsos CG, Breitner JC, Green RC, et al ADAPT Research Group. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 2007;68(21):1800-1808. (Pubitemid 46791392)
10. Oliff HS, Berchtold NC, Isackson P, Cotman CW. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res Mol Brain Res. 1998;61(1-2):147-153. (Pubitemid 28511357)